Skip to main content

/ The digest

What actually changed.

Regulation in this category moves faster than the content written about it, and most of that content is published by someone with a product to sell. This is the plain version: what happened, what the document actually says, and a link to the document. Monthly.

MonthlyPrimary source on every itemNo advice, everNo sponsors, no sellers

Monthly · unsubscribe in one click · we never sell or share your address

August 2026

5 items · August 2, 2026

Compounding narrows, and the category learns what "available" really meant

The regulatory picture for compounded GLP-1 medicines tightened again, while a separate HHS announcement moved most restricted peptides in the opposite direction. Both are real, they point different ways, and the difference is worth understanding.

Read the issue →

The digest reports regulatory and research developments. It does not tell anyone what to take, whether to start or stop anything, or how to respond to a change in the law. Those are conversations for a qualified clinician who knows your situation. Read how we source everything on this site on the sourcing and editorial policy page.